SCHEMBL25374816

SCHEMBL25374816

FC(F)(F)c1ccc(CNC2CC2)nc1.NC1CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 2/20 0.54
▸ MAOB P27338 2/20 0.54
▸ MAOA P21397 1/20 0.54
▸ HDAC1 Q13547 5/20 0.42
▸ HDAC8 Q9BY41 5/20 0.42
▸ HDAC6 Q9UBN7 5/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.39
▸ PAICS P22234 1/20 0.38
▸ TRPV3 Q8NET8 2/20 0.38
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ DPP4 P27487 1/20 0.38
▸ HMOX1 P09601 1/20 0.38
▸ CCNT1 O60563 1/20 0.37
▸ PDE2A O00408 1/20 0.37
▸ TEAD1 P28347 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19650813 0.94 KDM1A (0.59) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL29456936 0.94 KDM1A (0.59) KDM1AMAOBMAOAHDAC1HDAC8
Hydrochloric Acid SCHEMBL30615191 0.93 KDM1A (0.58) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL23545585 0.88 KDM1A (0.56) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL30471935 0.88 KDM1A (0.56) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL24468271 0.84 KDM1A (0.53) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL22787428 0.82 KDM1A (0.47) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL31137369 0.80 KDM1A (0.54) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL22787439 0.80 KDM1A (0.45) KDM1AMAOBMAOAHDAC1HDAC8
SCHEMBL31613889 0.79 KDM1A (0.47) KDM1AMAOBMAOANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146987-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback